FDA authorizes first commercial monkeypox test, pertussis vaccine for young infants
The Food and Drug Administration Friday authorized for the first commercial test kit to detect monkeypox in lesion swab specimens. Only laboratories certified under the Clinical Laboratory Improvement Amendments to perform moderate or high complexity tests are authorized to perform the Abbott Molecular test.
In other news, the FDA the first vaccine to administer to mothers during pregnancy to prevent whooping cough (pertussis) in infants under two months old. The Boostrix vaccine previously was approved to protect pregnant women, adults and children age 10 and older.
Related News Articles
Headline
Kevin McEwan, DNP, R.N., chief nursing officer at Madison Memorial Hospital, shares how Medicaid provides vital behavioral health and maternal and child care…
Headline
The Alliance for Innovation on Maternal Health, with support from the Health Resources and Services Administration, will host a five-part learning series…
Headline
Beth Heinz, senior vice president, Women’s and Children’s Services at Yale New Haven Health, and Cheri Johnson, chief nursing officer, Woman’s Hospital in…
Blog
One of our best strategies to address the unique behavioral health challenges and demands of pregnant women and new mothers is recognizing that mental health…
Headline
Rep. Robin Kelly, D-Ill., member of the Health Subcommittee of the Energy and Commerce Committee and chair of the Congressional Black Caucus Health Braintrust…
Headline
The American College of Obstetricians and Gynecologists April 17 released guidance recommending a new approach to prenatal care delivery. The guidance calls…